search
Search
IFFIm issues first vaccine bonds of 2011
Daiwa Securities Group, the International Finance Facility for Immunisation Company ("IFFIm"), the GAVI Alliance, and the World Bank announce IFFIm's first issue of "Vaccine Bonds" for 2011 Daiwa Securities Group Inc Tokyo, 9 March 2011 - Daiwa…
Japanese investors welcome the launch of IFFIm’s debut 'vaccine bonds'
Japanese investors welcomed the launch of the debut offering in the Japanese market of the International Finance Facility for Immunisation Company Tokyo, 4 March 2008 - Japanese investors enthusiastically welcomed the launch of the debut offering…
Japanese retail investors continue to show strong support for vaccine bonds
The most recent offering of vaccine bonds demonstrates Japanese investors' continued support for the International Finance Facility for Immunisation and its humanitarian purpose Tokyo, 24 June 2009 - Vaccine bonds offered to Japanese retail…
Investors welcome the return of IFFIm’s “Vaccine Bonds” to the Japanese debt market
Vaccine bonds offered to Japanese retail investors to help pay for health and immunisation programmes in the world's poorest countries "It is particularly gratifying to have been involved in the arrangement of this bond issue, the proceeds of which…
South Africa joins seven nations in backing the IFFIm
The Government of South Africa announced today that it will contribute US$20 million over 20 years to the International Finance Facility for Immunisation Geneva, 25 April 2006 - The Government of South Africa announced today that it will contribute…
Spectacular response to IFFIm’s inaugural financing
Today, the International Finance Facility for Immunisation (IFFIm), rated AAA/Aaa/AAA, priced its first ever capital markets financing, a USD 1 billion 5-year benchmark bond. The issue represents not only a landmark in the history of multilateral…
IFFIm returns to UK market with £250 million bond supporting Gavi immunisation programmes
Proceeds from the vaccine bonds will finance Gavi immunisation programmes including reaching “zero dose” children "In light of pandemic-driven setbacks in many countries Gavi supports, we are now focusing on building on past progress and reaching…
New IFFIm vaccine bonds issued to support life-saving immunisation in poorest countries
Bonds will support GAVI Alliance vaccine programmes Tokyo, 29 September 2011 - J.P. Morgan, the World Bank and the International Finance Facility for Immunisation ("IFFIm") (rated AAA/Aaa/AAA), today announced the issuance of US$ 169.4 million (…
IFFIm Vaccine Bonds for Japanese Investors
Increasing Immunisation of Children in the Poorest Countries. Issuance of about US$ 139 million of 5-year notes denominated in Turkish lira, South African rand. Tokyo, 28 March 2013 - Daiwa Securities Group, the International Finance Facility for…
IFFIm issues US$ 700 million in 3-year floating rate Vaccine Bonds
Funding to increase immunisation of children in the poorest countries London, 27 June 2013 – The International Finance Facility for Immunisation Company (IFFIm) today announced its inaugural US dollar floating rate benchmark. The US$ 700 million, 3…
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.